These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25529923)

  • 1. The susceptibility vessel sign at the proximal M1: a strong predictor for poor outcome after intravenous thrombolysis.
    Aoki J; Kimura K; Shibazaki K; Saji N; Uemura J; Sakamoto Y; Nagai K
    J Neurol Sci; 2015 Jan; 348(1-2):195-200. PubMed ID: 25529923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. M1 susceptibility vessel sign on T2* as a strong predictor for no early recanalization after IV-t-PA in acute ischemic stroke.
    Kimura K; Iguchi Y; Shibazaki K; Watanabe M; Iwanaga T; Aoki J
    Stroke; 2009 Sep; 40(9):3130-2. PubMed ID: 19556532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Location of the Susceptibility Vessel Sign on T2*-Weighted MRI and Early Recanalization within 1 Hour after Tissue Plasminogen Activator Administration.
    Aoki J; Kimura K; Shibazaki K; Sakamoto Y; Saji N; Uemura J
    Cerebrovasc Dis Extra; 2013; 3(1):111-20. PubMed ID: 24163686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic Resonance Imaging-DRAGON score: 3-month outcome prediction after intravenous thrombolysis for anterior circulation stroke.
    Turc G; Apoil M; Naggara O; Calvet D; Lamy C; Tataru AM; Méder JF; Mas JL; Baron JC; Oppenheim C; Touzé E
    Stroke; 2013 May; 44(5):1323-8. PubMed ID: 23482603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clot burden score on admission T2*-MRI predicts recanalization in acute stroke.
    Legrand L; Naggara O; Turc G; Mellerio C; Roca P; Calvet D; Labeyrie MA; Baron JC; Mas JL; Meder JF; Touzé E; Oppenheim C
    Stroke; 2013 Jul; 44(7):1878-84. PubMed ID: 23704103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with early recanalization failure following intravenous rt-PA therapy for ischemic stroke.
    Koga M; Arihiro S; Miyashita F; Yamamoto H; Yamada N; Nagatsuka K; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2013; 36(4):299-305. PubMed ID: 24135558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the Susceptibility Vessel Sign on 3-Tesla Magnetic Resonance T2*-Weighted Imaging a Useful Tool to Predict Recanalization in Intravenous Tissue Plasminogen Activator?
    Yamamoto N; Satomi J; Harada M; Izumi Y; Nagahiro S; Kaji R
    Clin Neuroradiol; 2016 Sep; 26(3):317-23. PubMed ID: 25516146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of magnetic resonance angiography-diffusion weighted imaging mismatch in hyperacute cerebral infarction.
    Deguchi I; Takeda H; Furuya D; Dembo T; Nagoya H; Kato Y; Ito Y; Fukuoka T; Maruyama H; Tanahashi N
    J Stroke Cerebrovasc Dis; 2012 Feb; 21(2):108-13. PubMed ID: 20851627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of middle cerebral artery susceptibility sign on T2*-weighted images: its effect on recanalization and clinical outcome after thrombolysis.
    Kim HS; Lee DH; Choi CG; Kim SJ; Suh DC
    AJR Am J Roentgenol; 2006 Dec; 187(6):W650-7. PubMed ID: 17114520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Length of occlusion predicts recanalization and outcome after intravenous thrombolysis in middle cerebral artery stroke.
    Rohan V; Baxa J; Tupy R; Cerna L; Sevcik P; Friesl M; Polivka J; Polivka J; Ferda J
    Stroke; 2014 Jul; 45(7):2010-7. PubMed ID: 24916912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphology of susceptibility vessel sign predicts middle cerebral artery recanalization after intravenous thrombolysis.
    Yan S; Hu H; Shi Z; Zhang X; Zhang S; Liebeskind DS; Lou M
    Stroke; 2014 Sep; 45(9):2795-7. PubMed ID: 25028445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large-Vessel Occlusion Stroke: Effect of Recanalization on Outcome Depends on the National Institutes of Health Stroke Scale Score.
    Skagen K; Skjelland M; Russell D; Jacobsen EA
    J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1532-9. PubMed ID: 25922156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infarct volume is a pivotal biomarker after intra-arterial stroke therapy.
    Yoo AJ; Chaudhry ZA; Nogueira RG; Lev MH; Schaefer PW; Schwamm LH; Hirsch JA; González RG
    Stroke; 2012 May; 43(5):1323-30. PubMed ID: 22426317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients.
    Kimura K; Iguchi Y; Shibazaki K; Kobayashi K; Uemura J; Aoki J; Yamashita S; Terasawa Y; Matsumoto N
    J Neurol Sci; 2008 Jul; 270(1-2):48-52. PubMed ID: 18304581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severity of leukoaraiosis, leptomeningeal collaterals, and clinical outcomes after intra-arterial therapy in patients with acute ischemic stroke.
    Giurgiutiu DV; Yoo AJ; Fitzpatrick K; Chaudhry Z; Leslie-Mazwi T; Schwamm LH; Rost NS
    J Neurointerv Surg; 2015 May; 7(5):326-30. PubMed ID: 24721756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stroke lesion volumes and outcome are not different in hemispheric stroke side treated with intravenous thrombolysis based on magnetic resonance imaging criteria.
    Golsari A; Cheng B; Sobesky J; Schellinger PD; Fiehler J; Gerloff C; Thomalla G
    Stroke; 2015 Apr; 46(4):1004-8. PubMed ID: 25700285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. M1 susceptibility vessel sign and hyperdense middle cerebral artery sign in hyperacute stroke patients.
    Sakamoto Y; Kimura K; Sakai K
    Eur Neurol; 2012; 68(2):93-7. PubMed ID: 22759539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous thrombolysis outcomes in patients presenting with large vessel acute ischemic strokes--CT angiography-based prognosis.
    Rai A; Cline B; Williams E; Carpenter J; Roberts T
    J Neuroimaging; 2015; 25(2):238-242. PubMed ID: 24888428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endovascular revascularization results in IMS III: intracranial ICA and M1 occlusions.
    Tomsick TA; Yeatts SD; Liebeskind DS; Carrozzella J; Foster L; Goyal M; von Kummer R; Hill MD; Demchuk AM; Jovin T; Yan B; Zaidat OO; Schonewille W; Engelter S; Martin R; Khatri P; Spilker J; Palesch YY; Broderick JP;
    J Neurointerv Surg; 2015 Nov; 7(11):795-802. PubMed ID: 25342652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three cases of middle cerebral artery occlusion emergently revascularized with a balloon-expandable coronary bare stent after intravenous tissue plasminogen activator.
    Fukuoka T; Dembo T; Nagoya H; Deguchi I; Maruyama H; Kanazawa R; Kohyama S; Yamane F; Ishihara S; Tanahashi N
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):883-9. PubMed ID: 21767964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.